塞法胺/阿维巴克坦单疗与其他抗生素:我们站在哪里?
Georgios Vougiouklakis1, Constantinos Tsioutis2, Nayia Vasileiadi1,2
1Department of Internal Medicine, German Medical Institute, Limassol 4108, Cyprus.
Pathogens (Basel, Switzerland)
|November 27, 2025
概括
塞法胺/阿维巴克坦 (CAZ/AVI) 有效对抗多药耐药的格拉姆阴性感染. 这种组合显示出良好的疗效和安全性,使其成为对抗细菌感染的最前沿选择.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多药耐药 (MDR) 病原体的增加,特别是那些产生β-乳糖酶的病原体,如扩展谱β-乳糖酶 (ESBLs),需要替代治疗方法.
- 产生卡巴酶的病原体的出现是一个重大的全球健康挑战,限制了治疗选择.
- 碳烯经常被用作最后一线抗生素,但耐药性正在增加.
研究的目的:
- 审查塞夫塔齐迪姆/阿维巴克坦 (CAZ/AVI) 治疗多药耐药格拉姆阴性感染的疗效和安全性.
- 评估CAZ/AVI在各种临床环境和患者群体中的性能.
- 为了比较CAZ/AVI与现有的治疗方法,如卡巴烯和多胺.
主要方法:
- 随机对照试验和队列研究的系统审查.
- 对CAZ/AVI的临床结果和安全数据的分析.
- 对CAZ/AVI针对安布勒A,C和D类β-乳酸酶的活性谱的评估.
主要成果:
- 阿维巴克坦抑制了广泛的β-乳酸酶,包括ESBL和卡巴酶 (KPC,OXA型).
- 在临床结果和安全性方面,CAZ/AVI 已证明与卡巴烯无劣,并且优于聚米克辛.
- 在各种感染中有效:复杂的腹内感染,尿道感染,医院肺炎,皮肤/软组织感染和血液感染.
结论:
- CAZ/AVI是一种强大的治疗选择,可以对抗耐药性格拉姆阴性病原体.
- 良好的疗效和安全概况支持其作为一线治疗的使用.
- 证据支持CAZ/AVI在高风险群体的使用,包括免疫功能低下和重症患者.
关键词:
格拉姆阴性菌乙-乳酸酶的存在碳烯的使用方法塞夫塔齐迪姆/阿维巴克坦类素是什么? 类素是什么 类素是什么临床结果的临床结果.组合组合组合的组合组合.抑制剂抑制剂的使用死亡率 死亡率多种药物耐药性多种药物耐药性更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
168
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
168
Antimicrobial Effectiveness
885
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
885
Antibiotic Selection
59.3K
Overview
59.3K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
799
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
799


